Hepatitis: Clinical Trials

21 trials for Hepatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 recruiting, 3 unknown, 3 withdrawn. 21 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 121Completed 7, Recruiting 3, Unknown 3, Withdrawn 3, Active not recruiting 2, Not yet recruiting 2, Terminated 1

Follow Hepatitis: new trials by email Literature Review of Hepatitis trials Research Report on Hepatitis

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
Peginterferon alfa-2b, TDF, TAF - Hepatocellular Carcinoma, HEPATITIS B CHRONIC
Early Phase 1Not yet recruitingNingbo No.2 Hospital1562026-03-312026-04-28
An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B
EPI-003 - Chronic Hepatitis B
Early Phase 1Not yet recruitingEpigenic Therapeutics, Inc202024-12-202024-12-24
Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania
sofosbuvir/velpatasvir (SOF/VEL), Shortened read time of rapid diagnostic test for hepatitis C virus. - Hepatitis C, RDT
Early Phase 1RecruitingMédecins du Monde30402024-10-032026-10-09
Study to Evaluate Immunogenicity and Safety of TVAX-008 Injection in Non/Treated Chronic Hepatitis B Patients With HBsAg≤20IU/ml or HBsAg Negative Without Serological Conversion
TVAX-008 - Chronic Hepatitis B
Early Phase 1Active not recruitingGrand Theravac Life Sciences (Nanjing) Co., Ltd.202024-01-182025-10-02
Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B
PEGylated recombinant human interferon alpha-2b injection - Hepatitis B, Chronic
Early Phase 1RecruitingAnhui Medical University10842023-07-012023-06-28
The Efficacy and Safety of Rifaximin Treatment
Rifaximin 200 mg, Standard Treatment without Rifaximin - Liver Failure, Acute on Chronic, Hepatic Encephalopathy
Early Phase 1UnknownSun Yat-sen University1242023-03-092023-03-28
A Study in Chronic Hepatitis B e-Antigen Negative Participants After Discontinuation of Nucleos(t)Ide Analog (NA) Treatment
Entecavir (ETV), Tenofovir Disoproxil Fumarate (TDF), Tenofovir Alafenamide (TAF) - Hepatitis B, Chronic
Early Phase 1WithdrawnJanssen Pharmaceutica N.V., Belgium2022-10-312025-06-25
Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients Sera
sofosbuvir and daclatasvir - Hepatitis C, Chronic
Early Phase 1UnknownAssiut University402022-10-012022-07-26
HA35 Moderate Alcoholic Hepatitis (AH) Study
Sodium Hyaluronate, Placebo - Alcoholic Hepatitis
Early Phase 1RecruitingThe Cleveland Clinic542022-09-012026-09-24
Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)
ChAdOx1 RVF - Rift Valley Fever
Early Phase 1CompletedUniversity of Oxford152021-06-112023-05-19
Efficacy and Safety of TAF in Pregnant Women With Chronic Hepatitis B Infection
Tenofovir Alafenamide 25 MG - Chronic Hepatitis B, Mother-to-child Block
Early Phase 1UnknownThird Affiliated Hospital, Sun Yat-Sen University502020-08-012020-12-22
Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD
Chronic Hepatitis B - Chronic Hepatitis B, Nonalcoholic Fatty Liver Disease
Early Phase 1CompletedSichuan Leshan Traditional Chinese Medicine Hospital922020-01-052022-08-31
Hepatitis C Positive Donor Into Hepatitis C Negative Recipients
Direct Acting Antivirals - Hepatitis C
Early Phase 1WithdrawnUniversity of Maryland, Baltimore2019-07-012023-05-06
Use of Erythropoietin to Expand Regulatory T Cells in Autoimmune Liver Disease
Erythropoietin - Autoimmune Hepatitis
Early Phase 1CompletedNorthwestern University62019-01-252021-03-04
Lung Transplant HCV, Pilot Study
Sofosbuvir-velpatasvir (400 mg/100 mg), Ex Vivo Lung Perfusion (EVLP) - Lung Transplant Infection, Hepatitis C
Early Phase 1Active not recruitingUniversity Health Network, Toronto262017-09-192026-05-11
Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients
Direct acting Anti-Viral Therapy using Epclusa or Zepatier - Kidney Transplant, Hepatitis C
Early Phase 1CompletedVirginia Commonwealth University252017-08-172020-03-27
Identification to Elimination in HCV-Infected Individuals
OraQuick HCV Rapid Antibody Test - Hepatitis C
Early Phase 1CompletedTruCare Internal Medicine & Infectious Disease30512017-06-012020-07-02
Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124
GS-4997, Prednisolone, HepQuant SHUNT Test - Severe Alcoholic Hepatitis
Early Phase 1WithdrawnHepQuant, LLC2016-07-312021-08-30
The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs
Ledipasvir-Sofosbuvir, Daclatasvir-Sofosbuvir - Chronic Hepatitis C
Early Phase 1CompletedThird Affiliated Hospital, Sun Yat-Sen University522016-02-012017-06-15
Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis
Ciprofloxacin, Placebo - Alcoholic Hepatitis, Alcoholic Cirrhosis
Early Phase 1CompletedUniversity of Helsinki222015-04-012017-01-19

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Hepatitis B, Chronic (7)  ·  Hepatitis C (5)  ·  Hepatitis C, Chronic (3)  ·  Hepatitis, Alcoholic (3)  ·  Hepatitis B (2)  ·  Acute-On-Chronic Liver Failure (1)  ·  Camurati-Engelmann Syndrome (1)  ·  Carcinoma, Hepatocellular (1)  ·  Fibrosis (1)  ·  Hepatic Encephalopathy (1)  ·  Hepatitis, Autoimmune (1)  ·  Liver Cirrhosis, Alcoholic (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Recurrence (1)

Broader conditions

Digestive System Diseases (21)  ·  Liver Diseases (21)  ·  Infections (17)  ·  Virus Diseases (17)  ·  Blood-Borne Infections (16)  ·  Communicable Diseases (16)  ·  Hepatitis, Viral, Human (16)  ·  Hepatitis, Chronic (11)  ·  Pathologic Processes (11)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Chronic Disease (10)  ·  Disease Attributes (10)  ·  RNA Virus Infections (9)  ·  DNA Virus Infections (8)

Interventions

Sofosbuvir (2)  ·  daclatasvir (2)  ·  sofosbuvir-velpatasvir drug combination (2)  ·  tenofovir alafenamide (2)  ·  Betaine (1)  ·  Ciprofloxacin (1)  ·  Erythropoietin (1)  ·  Hyaluronic Acid (1)  ·  Prednisolone (1)  ·  Ribavirin (1)  ·  Rifaximin (1)  ·  Tenofovir (1)  ·  elbasvir-grazoprevir drug combination (1)  ·  entecavir (1)  ·  ledipasvir, sofosbuvir drug combination (1)

Sponsors

Third Affiliated Hospital, Sun Yat-Sen University (2)  ·  Anhui Medical University (1)  ·  Assiut University (1)  ·  Epigenic Therapeutics, Inc (1)  ·  Grand Theravac Life Sciences (Nanjing) Co., Ltd. (1)  ·  HepQuant, LLC (1)  ·  Janssen Pharmaceutica N.V., Belgium (1)  ·  Médecins du Monde (1)  ·  Ningbo No.2 Hospital (1)  ·  Northwestern University (1)  ·  Sichuan Leshan Traditional Chinese Medicine Hospital (1)  ·  Sun Yat-sen University (1)  ·  The Cleveland Clinic (1)  ·  TruCare Internal Medicine & Infectious Disease (1)  ·  University Health Network, Toronto (1)

Countries

China (7)  ·  United States (7)  ·  Armenia (1)  ·  Canada (1)  ·  Egypt (1)  ·  Finland (1)  ·  United Kingdom (1)

Top investigators

Adrian VS Hill, Prof (1)  ·  Gaurav Gupta, MD (1)  ·  Greg Everson, MD (1)  ·  Jiabing Li, MD (1)  ·  Marcelo Cypel, MD MSc FRCSC (1)  ·  Margaret Hellard (1)  ·  Mark E Mailliard, MD (1)  ·  Perttu Sahlman, MD (1)  ·  Qin Yang, MM (1)  ·  Tuesdae R Stainbrook, DO, MPH (1)  ·  Zhi-liang Gao, PhD (1)

Results publications

PMID 10898704, PMID 20335583, PMID 21157444, PMID 23993913, PMID 25819304, PMID 26084406, PMID 27512927, PMID 28902040, PMID 28994123, PMID 31172417, PMID 31606437, PMID 31652392, PMID 31988585, PMID 32004593, PMID 32781201, PMID 33385299, PMID 33421158, PMID 33721837, PMID 34006193, PMID 35220659, PMID 36588741, PMID 37060917, PMID 41494657, PMID 41876153